These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1186741)

  • 1. Proceedings: Chemical mechanisms and biotransformations involved in triazene mutagenesis.
    Kolar GF
    Mutat Res; 1975 Aug; 29(2):236-7. PubMed ID: 1186741
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effects.
    Shusterman AJ; Debnath AK; Hansch C; Horn GW; Fronczek FR; Greene AC; Watkins SF
    Mol Pharmacol; 1989 Dec; 36(6):939-44. PubMed ID: 2601689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of triazene cytostatics.
    Kolar GF; Wildschütte M
    Adv Exp Med Biol; 1981; 136 Pt B():1285-96. PubMed ID: 7344512
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activity.
    Rouzer CA; Sabourin M; Skinner TL; Thompson EJ; Wood TO; Chmurny GN; Klose JR; Roman JM; Smith RH; Michejda CJ
    Chem Res Toxicol; 1996; 9(1):172-8. PubMed ID: 8924588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinostatics based on 1-phenyl-3,3-dimethyl triazene. IV. Kinetics and proteolytic cleavage].
    Matrka M; Rambousek V; Zvĕrina V
    Cesk Farm; 1978 Oct; 27(8):346-9. PubMed ID: 743752
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine- and tyramine-based derivatives of triazenes: activation by tyrosinase and implications for prodrug design.
    Perry MJ; Mendes E; Simplício AL; Coelho A; Soares RV; Iley J; Moreira R; Francisco AP
    Eur J Med Chem; 2009 Aug; 44(8):3228-34. PubMed ID: 19386398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of a transplacental mutagen, 1,3-Di(4-sulfamoylphenyl)triazene, from sodium nitrite and sulfanilamide in human gastric juice and in the stomachs of hamsters.
    Endo H; Noda H; Kinoshita N; Inui N; Nishi Y
    J Natl Cancer Inst; 1980 Sep; 65(3):547-51. PubMed ID: 6931934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro biotransformation of carbinolamine metabolites of cytotoxic dimethyltriazenes [proceedings].
    Gescher A; Hickman JA; Stevens MF
    Br J Pharmacol; 1979 Jul; 66(3):434P-435P. PubMed ID: 526723
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Tumour inhibitory triazenes.
    Wilman DE
    Br J Cancer; 1975 Aug; 32(2):246. PubMed ID: 1212368
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3-acyltriazenes depends on the structure of the acyl group: kinetic and product studies.
    Smith MB; Schmidt BF; Czerwinski G; Taneyhill LA; Snyder EJ; Kline AM; Michejda CJ; Smith RH
    Chem Res Toxicol; 1996 Mar; 9(2):466-75. PubMed ID: 8839051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Hydroxylated triazenes: potential active metabolites of anti-tumour dimethyltriazenes [proceedings].
    Stevens MF; Gescher A; Hickman JA; Vaughan K; Simmonds RJ
    J Pharm Pharmacol; 1978 Dec; 30 Suppl():48P. PubMed ID: 32304
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,3-Bis(4-methylphenyl)triazene, 1-(4-chlorophenyl)-3-(4-fluorophenyl)triazene and 1-(4-fluorophenyl)-3-(4-methylphenyl)triazene.
    Karadayi N; Cakmak S; Odabaşoğlu M; Büyükgüngör O
    Acta Crystallogr C; 2005 May; 61(Pt 5):o303-5. PubMed ID: 15876722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
    Malaveille C; Brun G; Kolar G; Bartsch H
    Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA alkylation by triazenes and related compounds.
    Michejda CJ; Smith RH; Kroeger Koepke MB
    IARC Sci Publ; 1994; (125):323-37. PubMed ID: 7806322
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor-acceptor triazenes: synthesis, characterization, and study of their electronic and thermal properties.
    Khramov DM; Bielawski CW
    J Org Chem; 2007 Dec; 72(25):9407-17. PubMed ID: 17608438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, metabolism, and disposition of 1,3-diphenyl-1-triazene in rats and mice after oral, i.v., and dermal administration.
    Mathews JM; De Costa KS
    Drug Metab Dispos; 1999 Dec; 27(12):1499-504. PubMed ID: 10570033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triazene metabolism. VI. 3-Azidomethyl-3-alkyl-1-aryltriazenes, a new class of anti-tumour triazene with potential pro-drug applications.
    Vaughan K; Nicholas G; Singer RD; Roy M; Gibson NW
    Anticancer Drug Des; 1987 Dec; 2(3):279-87. PubMed ID: 3449091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical xenogenization: antigenic changes of cancer cells induced by triazene compounds.
    Giuliani A; D'Atri S; Franchi A; Tricarico M; Tentori L; Bonmassar E
    Contrib Gynecol Obstet; 1991; 18():79-92. PubMed ID: 1718661
    [No Abstract]   [Full Text] [Related]  

  • 19. The combi-targeting concept: chemical dissection of the dual targeting properties of a series of "combi-triazenes".
    Rachid Z; Brahimi F; Katsoulas A; Teoh N; Jean-Claude BJ
    J Med Chem; 2003 Sep; 46(20):4313-21. PubMed ID: 13678409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base sequence selectivity in the alkylation of DNA by 1,3-dialkyl-3-acyltriazenes.
    Kroeger Smith MB; Taneyhill LA; Michejda CJ; Smith RH
    Chem Res Toxicol; 1996; 9(1):341-8. PubMed ID: 8924614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.